vimarsana.com

Page 9 - தொழில்நுட்பம் சங்கம் ஆஃப் ஜார்ஜியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Venture Atlanta Board Represents Diversity and Reflects Dedication to Continuing the Momentum From 2020 s Success

New Venture Atlanta Board Represents Diversity and Reflects Dedication to Continuing the Momentum From 2020 s Success Top investment conference selects largest, most diverse lineup of board members News provided by Share this article Share this article ATLANTA, Feb. 8, 2021 /PRNewswire/  Venture Atlanta, the largest and most prestigious venture conference in the Southeast, today announced this year s board of directors, a diverse and multifaceted group of entrepreneurs, business leaders and investment executives dedicated to moving the technology industry forward to solve current challenges. The board will focus on continuing to build off of the momentum of 2020 s record-breaking virtual conference, Venture Atlanta Live Online, a successful pivot from its traditional in-person event that was watched by over 1,200 people worldwide. The 2020 conference resulted in not only raising capital for participating companies, but also delivered meaningful engagement and discussions on

Fast-Growing Oncology Startup OncoLens Secures $7 25 Million Series A Funding

Share this article Share this article ATLANTA, Jan. 13, 2021 /PRNewswire/  OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced today that it has raised a $7.25 million Series A investment from BIP Capital, Martin Ventures, and SeedToB Capital, a new healthcare artificial intelligence (AI) venture fund launched by former Jvion Co-founders Shantanu Nigam and Ritesh Sharma. OncoLens brings collaborative and personalized treatment planning to the cancer patient through data integration and decision support. It helps cancer programs and their multidisciplinary teams of specialists collaborate effectively while easily aggregating patient-specific data in a HIPAA-compliant manner across different EMR/clinical/genetics information systems. Patient-specific clinical trials at a facility or its affiliates, NCCN/ASCO guidelines, and the latest research are also automatically identified for each case to support the care team in making the best decision f

MAXEX Exceeds $13 Billion in Non-Agency Lock Trading Volume |

MAXEX Exceeds $13 Billion in Non-Agency Lock Trading Volume By Staff 4 months ago Rapidly growing mortgage exchange more than doubles non-agency volume in first 11 calendar months of 2020 despite the ongoing COVID-19 pandemic ATLANTA–(BUSINESS WIRE)–$JPM#mortgage–MAXEX today announced that lock trading volume in non-agency mortgages on its digital exchange has exceeded $13 billion, more than double its total volume over the previous three years. MAXEX, which was launched in 2016, has become a preferred liquidity provider for a growing number of bank and non-bank mortgage lenders and a source of quality loans for many of the industry’s leading institutional investors. To date more than 150 lenders and 19 of the industry’s most active investors have been approved to buy and sell loans with MAXEX. The company announced that it had exceeded $5 billion in lock trading volume at the end of 2019. It more than doubled its jumbo loan volumes in the first 11 months of 2020 de

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.